SRPT
Sarepta Therapeutics Inc
17.50$
-0.4%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 55.8 | – | |
| – | 685.4 | 236.0 | 725.8 | 69.3 | 345.8 | 153.5 | 126.0 | 200.7 | 32.7 | 1,461.6 | 6.9 | 2.2 | 7.9 | 7.9 | 2.1 | 16.3 | 48.6 | 59.5 | 1,302.8 | 246.1 | 21.2 | 24.0 | 24.9 | 24.6 | 10.4 | 12.2 | 7.2 | 6.9 | 1.0 | |
| – | 3.7 | 5.2 | 6.1 | 2.7 | 8.0 | 5.5 | 2.8 | 3.3 | 2.9 | 4.5 | 2.9 | 2.9 | 5.9 | – | 3.1 | 4.9 | 2.8 | 2.3 | 8.6 | 4.0 | 4.1 | 7.0 | 11.6 | 17.4 | 7.9 | 29.5 | 10.4 | 8.6 | 2.0 | |
| – | – | – | – | – | – | – | – | – | – | – | 4.8 | 1.7 | 5.3 | 6.9 | 1.3 | 11.3 | 29.9 | 52.6 | 1,257.4 | 226.5 | 20.1 | 24.6 | 24.6 | 24.0 | 9.4 | 12.8 | 7.8 | 6.9 | 1.0 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 41.5 | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 526.1 | – | – | – | – | – | |
| – | -4.8% | -19.1% | -10.7% | -11.1% | -7.0% | -17.9% | -15.6% | -28.8% | -10.3% | -13.1% | -35.5% | -29.6% | -7.7% | -7.3% | -26.7% | -5.1% | -9.9% | -26.8% | -9.5% | -18.9% | -7.7% | -6.3% | -5.4% | 0.2% | -6.6% | -3.2% | -6.6% | -2.7% | -13.6% | |
| Margins | ||||||||||||||||||||||||||||||
| 600.0% | 600.0% | 200.0% | 100.0% | 132.1% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 6.7% | 23.5% | -39.1% | -535.0% | -864.5% | 100.0% | 97.6% | 95.2% | 88.6% | 85.1% | 88.3% | 86.2% | 85.0% | 87.9% | 83.2% | 59.9% | |
| -2,200.0% | -3,900.0% | -3,850.0% | -8,300.0% | -789.4% | -2,181.4% | -3,028.4% | -1,946.0% | -5,817.9% | -366.2% | -28,608.5% | -301.4% | -129.2% | -88.2% | -71.2% | -76.5% | -79.6% | -635.0% | -1,371.2% | -17,572.5% | -4,920.3% | -111.0% | -114.1% | -185.3% | -104.5% | -65.5% | -57.5% | -21.5% | 11.5% | -29.9% | |
| -2,100.0% | -3,600.0% | -13,350.0% | -8,300.0% | -712.2% | -3,813.2% | -3,508.6% | -1,507.1% | -5,756.1% | -348.6% | -26,951.8% | -247.3% | -112.7% | -143.1% | -109.4% | -4.9% | -324.9% | -787.6% | -1,391.7% | -17,560.3% | -4,930.2% | -32.8% | -120.2% | -187.8% | -102.6% | -59.7% | -75.4% | -43.1% | 12.4% | -32.5% | |
| -1,700.0% | -3,300.0% | -4,500.0% | -7,800.0% | -766.3% | -2,407.5% | -2,753.5% | -1,971.5% | -5,773.4% | -337.3% | -19,140.5% | -244.0% | -63.8% | -61.4% | -58.3% | -55.3% | -82.6% | -481.5% | -1,592.3% | -12,314.3% | -4,661.2% | -163.8% | -150.5% | -135.5% | 4.7% | -68.6% | -38.3% | -47.3% | -18.5% | -14.0% | |
| Returns | ||||||||||||||||||||||||||||||
| -262.5% | -19.7% | -296.7% | -69.7% | -27.7% | -88.2% | -125.0% | -33.7% | -94.3% | -31.1% | -82.4% | -103.0% | -152.3% | -106.5% | – | -7.5% | -98.1% | -45.3% | -54.8% | -115.6% | -79.4% | -6.4% | -35.1% | -87.4% | -72.7% | -45.1% | -182.7% | -62.4% | 15.4% | -62.5% | |
| -50.0% | -19.1% | -261.8% | -64.3% | -26.3% | -79.6% | -102.6% | -31.0% | -86.9% | -29.6% | -76.0% | -70.3% | -93.8% | -41.9% | -70.0% | -4.3% | -59.2% | -38.4% | -46.0% | -80.4% | -63.0% | -3.9% | -22.0% | -39.2% | -18.6% | -13.3% | -22.5% | -16.4% | 5.9% | -21.3% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | -23 | -9.1 | -46 | -32 | -38 | -186 | -265 | -67 | -57 | -106 | -169 | 184 | -145 | -317 | -747 | 593 | 827 | 48 | 39 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.2 | – | |
| 19.0% | 97.3% | 88.2% | 92.2% | 95.1% | 90.3% | 82.1% | 92.0% | 92.1% | 95.1% | 92.3% | 68.3% | 61.6% | 39.4% | -6.1% | 57.1% | 60.3% | 84.8% | 83.9% | 69.5% | 79.4% | 60.3% | 62.9% | 44.9% | 25.5% | 29.5% | 12.3% | 26.3% | 38.5% | 34.1% | |
| – | – | – | – | – | – | – | – | – | – | – | 0.1 | 0.1 | 0.1 | – | 0.1 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.5 | 0.5 | 0.8 | 1.6 | 1.5 | 4.1 | 1.5 | 0.8 | 0.7 | |
| Per Share | ||||||||||||||||||||||||||||||
| -1.50 | -2.14 | -13.57 | -3.71 | -2.96 | -7.21 | -6.86 | -2.94 | -4.13 | -2.24 | -3.54 | -3.02 | -2.07 | -1.62 | -1.74 | -0.11 | -5.14 | -3.31 | -3.39 | -5.20 | -5.49 | -0.86 | -5.46 | -9.71 | -7.11 | -5.15 | -8.03 | -5.80 | 2.18 | -6.81 | |
| 0.07 | 0.06 | 0.10 | 0.04 | 0.42 | 0.19 | 0.20 | 0.20 | 0.07 | 0.64 | 0.01 | 1.22 | 1.84 | 1.13 | 1.59 | 2.18 | 1.58 | 0.42 | 0.24 | 0.03 | 0.11 | 2.63 | 4.54 | 5.17 | 6.93 | 8.64 | 10.66 | 13.46 | 17.63 | 20.98 | |
| 0.57 | 10.89 | 4.58 | 5.31 | 10.69 | 8.18 | 5.48 | 8.73 | 4.38 | 7.21 | 4.30 | 2.93 | 1.36 | 1.52 | -0.15 | 1.44 | 5.24 | 7.30 | 6.19 | 4.50 | 6.91 | 13.42 | 15.58 | 11.11 | 9.77 | 11.42 | 4.40 | 9.30 | 14.16 | 10.88 | |
| -1.21 | -1.96 | -4.58 | -3.48 | -3.19 | -4.55 | -5.38 | -3.85 | -4.14 | -2.17 | -2.51 | -2.98 | -1.17 | -0.70 | -0.93 | -1.20 | -1.31 | -2.02 | -3.88 | -3.65 | -5.19 | -4.30 | -6.84 | -7.01 | 0.32 | -5.93 | -4.08 | -6.37 | -3.27 | -2.93 | |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.